OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
Xiaoting Zhou, Yanghong Ni, Xiao Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Xiaoting Zhou, Yanghong Ni, Xiao Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Showing 26-50 of 49 citing articles:
Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer
Jie Chen, Rumeng Li, Yajie Cheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Jie Chen, Rumeng Li, Yajie Cheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma
Silje Beckinger, Tina Daunke, Leon Aldag, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Silje Beckinger, Tina Daunke, Leon Aldag, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers?
María Bucci-Muñoz, Aldana Magalí Gola, Juan Pablo Rigalli, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1633-1633
Open Access | Times Cited: 5
María Bucci-Muñoz, Aldana Magalí Gola, Juan Pablo Rigalli, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1633-1633
Open Access | Times Cited: 5
Bacterial therapy: a promising strategy for cancer immunotherapy
Yinsong Wang
Cancer Biology and Medicine (2023), pp. 1-4
Open Access | Times Cited: 5
Yinsong Wang
Cancer Biology and Medicine (2023), pp. 1-4
Open Access | Times Cited: 5
IFNγ mediates the resistance of tumor cells to distinct NK cell subsets
Tomáš Hofman, Siu Wang Ng, Irene Garces, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009410-e009410
Open Access | Times Cited: 1
Tomáš Hofman, Siu Wang Ng, Irene Garces, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009410-e009410
Open Access | Times Cited: 1
Applications of pyroptosis activators in tumor immunotherapy
Xin Bao, Mengmeng Sun, Lingfei Meng, et al.
Materials Today Bio (2024) Vol. 28, pp. 101191-101191
Open Access | Times Cited: 1
Xin Bao, Mengmeng Sun, Lingfei Meng, et al.
Materials Today Bio (2024) Vol. 28, pp. 101191-101191
Open Access | Times Cited: 1
Emerging Gene-editing nano-therapeutics for Cancer
Najma Nujoom, Manzoor Koyakutty, Lalitha Biswas, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39323-e39323
Open Access | Times Cited: 1
Najma Nujoom, Manzoor Koyakutty, Lalitha Biswas, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39323-e39323
Open Access | Times Cited: 1
P-stalk ribosomes act as master regulators of cytokine-mediated processes
Anna Dopler, Ferhat Alkan, Yuval Malka, et al.
Cell (2024) Vol. 187, Iss. 24, pp. 6981-6993.e23
Open Access | Times Cited: 1
Anna Dopler, Ferhat Alkan, Yuval Malka, et al.
Cell (2024) Vol. 187, Iss. 24, pp. 6981-6993.e23
Open Access | Times Cited: 1
Nanomedicines harnessing cGAS-STING pathway: sparking immune revitalization to transform ‘cold’ tumors into ‘hot’ tumors
Xiaohong Ying, Qiaohui Chen, Yongqi Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Xiaohong Ying, Qiaohui Chen, Yongqi Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Tumor Mutation Burden as a Cornerstone in Precision Oncology Landscapes: Effect of Panel Size and Uncertainty in Cutoffs
Betül Budak, Kazım Yalçın Arğa
OMICS A Journal of Integrative Biology (2024) Vol. 28, Iss. 4, pp. 193-203
Closed Access
Betül Budak, Kazım Yalçın Arğa
OMICS A Journal of Integrative Biology (2024) Vol. 28, Iss. 4, pp. 193-203
Closed Access
Multidimensional analysis of TMEM132A in pan-cancer: unveiling its potential as a biomarker for treatment response prediction
Mingyue Zhang, Shengli Wang, Meihong He, et al.
Journal of Cancer (2024) Vol. 15, Iss. 13, pp. 4386-4405
Open Access
Mingyue Zhang, Shengli Wang, Meihong He, et al.
Journal of Cancer (2024) Vol. 15, Iss. 13, pp. 4386-4405
Open Access
Reduced EO771-induced tumour growth and increased overall-survival of mice ablated for immune cell-specific catalytic subunit Cβ2 of protein kinase A
Shuai Guo, Shrikant S. Kolan, Gaoyang Li, et al.
Immunology Letters (2024) Vol. 268, pp. 106884-106884
Open Access
Shuai Guo, Shrikant S. Kolan, Gaoyang Li, et al.
Immunology Letters (2024) Vol. 268, pp. 106884-106884
Open Access
Reversal of T-cell exhaustion: Mechanisms and synergistic approaches
Yang Hu, Yaqi Zhang, Fenfen Shi, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112571-112571
Closed Access
Yang Hu, Yaqi Zhang, Fenfen Shi, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112571-112571
Closed Access
Regulation of Tumor Microenvironment Under Malignant Conditions: Application of nMOFs in Sonodynamic Therapy
Yilin Yang, Fei Yan, Zhan Shi
Chemical Research in Chinese Universities (2024)
Closed Access
Yilin Yang, Fei Yan, Zhan Shi
Chemical Research in Chinese Universities (2024)
Closed Access
Receptor-Based Strategies for Overcoming Resistance in Cancer Therapy
Naresh Sah, Abdul Althaf Shaik, Ganesh Acharya, et al.
Receptors (2024) Vol. 3, Iss. 4, pp. 425-443
Open Access
Naresh Sah, Abdul Althaf Shaik, Ganesh Acharya, et al.
Receptors (2024) Vol. 3, Iss. 4, pp. 425-443
Open Access
Emerging druggable targets for immune checkpoint modulation in cancer immunotherapy: the iceberg lies beneath the surface
Sakuntala Gayen, Swarupananda Mukherjee, Sandipan Dasgupta, et al.
APOPTOSIS (2024)
Closed Access
Sakuntala Gayen, Swarupananda Mukherjee, Sandipan Dasgupta, et al.
APOPTOSIS (2024)
Closed Access
Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers
Armin Nejat Dehkordi, Moein Maddahi, Parinaz Vafa, et al.
Clinical & Translational Oncology (2024)
Closed Access
Armin Nejat Dehkordi, Moein Maddahi, Parinaz Vafa, et al.
Clinical & Translational Oncology (2024)
Closed Access
Single-Nuclei Transcriptome Profiling Reveals Intra-Tumoral Heterogeneity and Characterizes Tumor Microenvironment Architecture in a Murine Melanoma Model
Sushant Parab, Valery Sarlo, Sonia Capellero, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11228-11228
Open Access
Sushant Parab, Valery Sarlo, Sonia Capellero, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11228-11228
Open Access
Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target
Clément Klein, Samy Mebroukine, Mathilde Madéry, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1779-1779
Open Access
Clément Klein, Samy Mebroukine, Mathilde Madéry, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1779-1779
Open Access
Enhancing cancer care with improved checkpoint inhibitors: a focus on PD-1/PD-L1.
A.S. Vickram, Saghya Infant Shofia, A. Saravanan, et al.
PubMed (2024) Vol. 23, pp. 1303-1326
Closed Access
A.S. Vickram, Saghya Infant Shofia, A. Saravanan, et al.
PubMed (2024) Vol. 23, pp. 1303-1326
Closed Access
Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer
Desh Deepak Singh, Shafiul Haque, Youngsun Kim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Desh Deepak Singh, Shafiul Haque, Youngsun Kim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Can senolysis be used to overcome tumor immune evasion?
Wally Veklych, Thomas E. Ichim, Robert Reznik, et al.
Journal of Stem Cell Research & Therapeutics (2024) Vol. 9, Iss. 1, pp. 26-32
Open Access
Wally Veklych, Thomas E. Ichim, Robert Reznik, et al.
Journal of Stem Cell Research & Therapeutics (2024) Vol. 9, Iss. 1, pp. 26-32
Open Access
Breast Cancer Stem Cells Targeted Strategies
N. L. Swathi, Ishwar Basavan, Evaristus Chinonso Odoh, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 151-176
Closed Access
N. L. Swathi, Ishwar Basavan, Evaristus Chinonso Odoh, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 151-176
Closed Access
Lumican is a potential predictor on the efficacy of concurrent chemoradiotherapy in cervical squamous cell carcinoma
Ge Hu, Ying Xiao, Chanchan Ma, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18011-e18011
Open Access | Times Cited: 1
Ge Hu, Ying Xiao, Chanchan Ma, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18011-e18011
Open Access | Times Cited: 1
An “alert state” ribosome population acts as a master regulator of cytokine-mediated processes
Anna Dopler, Ferhat Alkan, Yuval Malka, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Anna Dopler, Ferhat Alkan, Yuval Malka, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
